Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Brian J Gates, Trang T Nguyen, Stephen M Setter & Neal M Davies. (2005) Meloxicam: a reappraisal of pharmacokinetics, efficacy and safety. Expert Opinion on Pharmacotherapy 6:12, pages 2117-2140.
Read now
Read now
D. J. Watson, J. A. Bolognese, C. Yu, D. Krupa & S. Curtis. (2004) Use of gastroprotective agents and discontinuations due to dyspepsia with the selective cyclooxygenase-2 inhibitor etoricoxib compared with non-selective NSAIDs*. Current Medical Research and Opinion 20:12, pages 1899-1908.
Read now
Read now
Articles from other publishers (29)
Alison Small, Andrew David Fisher, Caroline Lee & Ian Colditz. (2021) Analgesia for Sheep in Commercial Production: Where to Next?. Animals 11:4, pages 1127.
Crossref
Crossref
Pei-Kang Liu, Yao-Tseng Wen, Wei Lin, Kishan Kapupara, Minghong Tai & Rong-Kung Tsai. (2020) Neuroprotective effects of low-dose G-CSF plus meloxicam in a rat model of anterior ischemic optic neuropathy. Scientific Reports 10:1.
Crossref
Crossref
Renáta Šelešovská, Frederika Hlobeňová, Jana Skopalová, Petr Cankař, Lenka Janíková & Jaromíra Chýlková. (2020) Electrochemical oxidation of anti-inflammatory drug meloxicam and its determination using boron doped diamond electrode. Journal of Electroanalytical Chemistry 858, pages 113758.
Crossref
Crossref
Qikun Jiang, Jin Wang, Panqin Ma, Cuiru Liu, Mengchi Sun, Yinghua Sun & Zhonggui He. (2017) Ion-pair formation combined with a penetration enhancer as a dual strategy to improve the transdermal delivery of meloxicam. Drug Delivery and Translational Research 8:1, pages 64-72.
Crossref
Crossref
Shih-Wei Lai, Cheng-Li Lin & Kuan-Fu Liao. (2015) Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case–Control Study. Clinical Drug Investigation 35:10, pages 653-657.
Crossref
Crossref
Wenji Zhang, Dongni Zu, Jianting Chen, Junjie Peng, Yun Liu, Hefeng Zhang, Sanming Li & Weisan Pan. (2014) Bovine serum albumin–meloxicam nanoaggregates laden contact lenses for ophthalmic drug delivery in treatment of postcataract endophthalmitis. International Journal of Pharmaceutics 475:1-2, pages 25-34.
Crossref
Crossref
Xin Tang, Fu-Xing Pei, Zong-Ke Zhou, Gang Liu, Bin Shen, Peng-De Kang, Jian Li, Xiao-Dan Zhao, Qi Li & Yong Li. (2012) A randomized, single-blind comparison of the efficacy and tolerability of hyaluronate acid and meloxicam in adult patients with Kashin–Beck disease of the knee. Clinical Rheumatology 31:7, pages 1079-1086.
Crossref
Crossref
Jonathan L Marks, Alexandra N Colebatch, Rachelle Buchbinder & Christopher J Edwards. (2011) Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity. Cochrane Database of Systematic Reviews.
Crossref
Crossref
. 2006. Wiley Handbook of Current and Emerging Drug Therapies. Wiley Handbook of Current and Emerging Drug Therapies.
. 2006. Wiley Handbook of Current and Emerging Drug Therapies. Wiley Handbook of Current and Emerging Drug Therapies.
Arvind CHOPRA, L. BICHILE, A. G. RAJADHYAKSHA, D. GADGIL, S. MAROLI, A. B. GOREGAONKAR & B. K. DHAON. (2004) Randomized double-blind clinical drug trials of meloxicam in rheumatoid arthritis and osteoarthritis knees: an Indian experience. APLAR Journal of Rheumatology 7:2, pages 108-116.
Crossref
Crossref
Isabel Villegas, Carmen La Casa, Catalina Alarcón de la Lastra, Virginia Motilva, Juan Manuel Herrerı́as & Marı́a José Martı́n. (2004) Mucosal damage induced by preferential COX-1 and COX-2 inhibitors: Role of prostaglandins and inflammatory response. Life Sciences 74:7, pages 873-884.
Crossref
Crossref
Robert Legenstein, Peter B?sch & Alfred Ungersb?ck. (2003) Indomethacin versus meloxicam for prevention of heterotopic ossification after total hip arthroplasty. Archives of Orthopaedic and Trauma Surgery 123:2-3, pages 91-94.
Crossref
Crossref
Antonia M. Joussen, Vassiliki Poulaki, Nicholas Mitsiades, Bernd Kirchhof, Kan Koizumi, Sven Döhmen & Anthony P. Adamis. (2002) Nonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppression. The FASEB Journal 16:3, pages 438-440.
Crossref
Crossref
F. Mayrhofer. (2014) Efficacy and Long-term Safety of Dexibuprofen [S(+)-Ibuprofen]: A Short-term Efficacy Study in Patients with Osteoarthritis of the Hip and a 1-Year Tolerability Study in Patients with Rheumatic Disorders. Clinical Rheumatology 20:S1, pages 22-29.
Crossref
Crossref
Isabel Villegas, Catalina Alarcón de la Lastra, Carmen La Casa, Virginia Motilva & Ma Jose Martı́n. (2001) Effects of food intake and oxidative stress on intestinal lesions caused by meloxicam and piroxicam in rats. European Journal of Pharmacology 414:1, pages 79-86.
Crossref
Crossref
Keith Louden & Guy Skinner. (2001) Dysmenorrhoea. The Obstetrician & Gynaecologist 3:1, pages 13-17.
Crossref
Crossref
D. Türck, G. Heinzel & G. Luik. (2001) Steady‐state pharmacokinetics of lithium in healthy volunteers receiving concomitant meloxicam. British Journal of Clinical Pharmacology 50:3, pages 197-204.
Crossref
Crossref
Frank Degner, Ralf Sigmund & Henning Zeidler. (2000) Efficacy and tolerability of meloxicam in an observational, controlled cohort study in patients with rheumatic disease. Clinical Therapeutics 22:4, pages 400-410.
Crossref
Crossref
John R Vane & Regina M Botting. (2000) The future of NSAID therapy: selective COX‐2 inhibitors. International Journal of Clinical Practice 54:1, pages 7-9.
Crossref
Crossref
J. R. Vane. 2000. Advances in Eicosanoid Research. Advances in Eicosanoid Research
1
23
.
Manathip Osiri & Larry W. Moreland. (1999) Specific Cyclooxygenase 2 Inhibitors: A New Choice of Nonsteroidal Anti-Inflammatory Drug Therapy. Arthritis & Rheumatism 12:5, pages 351-362.
Crossref
Crossref
P. Brooks, P. Emery, J. F. Evans, H. Fenner, C. J. Hawkey, C. Patrono, J. Smolen, F. Breedveld, R. Day, M. Dougados, E. W. Ehrich, J. Gijon-Baños, T. K. Kvien, M. H. Van Rijswijk, T. Warner & H. Zeidler. (1999) Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2. Rheumatology 38:8, pages 779-788.
Crossref
Crossref
Katja F. Daoud, Christopher G. Jackson & H. James Williams. (1999) Basic therapy for rheumatoid arthritis: Nonsteroidal anti-inflammatory drugs. Comprehensive Therapy 25:8-10, pages 427-433.
Crossref
Crossref
Franz von Bruchhausen, Siegfried Ebel, Eberhard Hackenthal, Ulrike Holzgrabe, Margitta Albinus, Gudrun Amschler, Erwin von Angerer, C. Arras-Reiter, Andrea Bauer, Pia Bauer, Winfried Beil, Thorsten Beyrich, Katja Binder, Roswitha Böhme, Hans-Hubertus Borchert, Franz Bossle, Franz Bracher, Helmut Bräunlich, Ellen Bretschneider, Regina Brigelius-Flohé, Kerstin Brinkmann, Axel Büge, Wolfram Christ, Monika Cimbollek, Rolf Daniels, Gerd Dannhardt, Hans-Jürgen Duchstein, Kurt Eger, Petra Eichhorn, Michael Engler, Thomas Erker, Peter Felfe, Alfred Fenyves, Reinhard Fescharek, Carmen Frackenpohl, August Wilhelm Frahm, Margarete Frahm, Volker Franke, Ulrich Franken, Detlef Geffken, Uli Geis, Erika Glusa, Berthold Göber, Peter Ndive Gobina, Werner Golder, Margarete Goppelt-Strübe, Katharina Götte, Erkme Gottstein, Michael Grosam, Markus von Gruchalla, Michael Gütschow, Annette Häfner, Boris Haluszczynski, Achim Harder, Sabine Hartmann, Susanne Hartmann, Dieter Heber, Gerhard Heinemeyer, Eberhard Heller, Dietrich von Herrath, J. Hilfenhaus, Ute Hoffmann-Schollmayer, Bernhard Hofmann, Christian Holpert, Ute Hübner-Steiner, Elisabeth Inkmann, Jens Jürgens, Brigitte Kaiser, Dieter-Abbo Kalbhen, Hans Kemmler, Werner Kiefer, Christoph Klett, Stephanie Klett, Martin Klingmüller, Hans-Peter Klöcking, Gerd Kobal, Axel Kramer, Mareta Kreher, M. Krüger, Markus Kuhn, Marion Sylvia Lehner, Detlef Leopoldt, Georg Liedtke, Detlef Manns, Wolfgang Matthiessen, Andreas Maurer, Wolfgang Meindl, Klaus Menges, Paul Messinger, Frank Peter Meyer, Wolfgang Meyerhof, Manfred Moos, Rudolf Morgenstern, Klaus Müller, Walter E. Müller, Corina Nachtsheim, Tilo Netzer, Michael Neugebauer, Werner Neupert, Peter Nickel, Peter Nuhn, Bernd Nürnberg, H. Oelschläger, Joachim Oertel, Michael Oettel, Hartmut Oßwald, Robert Ott, Tilmann Ott, Thomas Otzen, Peter Pachaly, Helmut Pelzer, Karl-Uwe Petersen, Rainer Pick, Martina Pickert, Andreas Pies, Eberhard Reimann, Joachim Richter, Kai Riecke, Suzanne Ritter, Hans Rommelspacher, Ulrich Rose, Gernot Roth, Gerhard Rücker, Judith Schäfer, Joachim G. Schantl, Helmut Schlager, Hildegard Schleinitz, Max Schmauß, Helmut Schmidhammer, Gerhard Schmidt, Timo Schmidt, B. Schneeweiß, Johannes Schräder, Thomas Schulz, Gert Schulze, Peter Schwanz, Johannes Schweiger, Gisela Skopp, Gisela Skorka, Kai Smolinka, Ulrich Speck, Ralf Stahlmann, Herbert Stein, Karlheinz Stiefvater, Karl-Heinz Surborg, Ulf Sürig, Hubert Szelényi, Istvan Szelenyi, Alfred Täufel, Ruth Thieroff-Ekerdt, Reinhard Troschütz, Michael Verborg, Eugen J. Verspohl, Sabine Vogel, Franz-Josef Volk, Thomas Vorwerk, Jürgen Wallmann, Martin Wenzel, Marion Weyandt-Spangenberg, Sandra Wich, Reinhold Wintersteiger, Frauke Woltmann, Beate Wüst, G. Zilow & A. Kluge. 1999. Hagers Handbuch der Pharmazeutischen Praxis. Hagers Handbuch der Pharmazeutischen Praxis
71
233
.
Neville D. Yeomans, Gregory A. Cook & Andrew S. Giraud. (1998) Selective COX-2 inhibitors: Are they safe for the stomach?. Gastroenterology 115:1, pages 227-229.
Crossref
Crossref
J. R. Vane & R. M. Botting. 1998. Selective COX-2 Inhibitors. Selective COX-2 Inhibitors
1
17
.
John R. Vane & Renia M. Botting. (1997) Mechanism of action of aspirin-like drugs. Seminars in Arthritis and Rheumatism 26, pages 2-10.
Crossref
Crossref
John R. Vane & Regina M. Botting. 1997. Recent Advances in Prostaglandin, Thromboxane, and Leukotriene Research. Recent Advances in Prostaglandin, Thromboxane, and Leukotriene Research
131
138
.